Novartis researchers are searching for more effective ways to discover drugs for neurological and psychiatric diseases.

A researcher in South Africa investigating a rare skin disease was losing hope of a breakthrough. Then she made a discovery.

Collaborations are driving advances in sickle cell disease research, bringing new hope to patients.

The word “biopsy” typically conjures images of large needles. Lab technicians—and scientists working to discover new medicines—need enough tissue from a patient to prepare and evaluate a sample.

Using new technologies, researchers have developed a deeper understanding of how cells function, changing conceptions of disease.

A cellular computing error wreaks havoc on vision.

In a medical treatment facility on the Thai-Burmese border, 21 patients infected with malaria recently participated in a clinical trial.

Novartis works tirelessly with third-party organizations to improve access to cancer care.

Boston University developed a methodology to evaluate the impact of Novartis Access in Kenya. Peter C. Rockers tells us about the ongoing study.